This report is a landmark study based on interviews with 149 decision-makers from around the world representing 95 unique pharma and biotech companies.
Respondents discuss in detail their plans for study conduct and outsourcing across various Late Phase study categories. In addition, respondents provide their perceptions of - and experiences with - dozens of Late Phase service providers.
This report contains the following three sections:
• Late Phase Trends and Market Sizing
• Service Provider Dynamics
• Decision Making for Late Phase Studies
Scope of the report:
• Late Phase market size and growth potential
• Late Phase service provider service quality and customer loyalty
• What drives sponsors' selection of Late Phase service providers
• What drives sponsors' satisfaction with Late Phase service delivery
• The complex decision-making units within sponsor companies
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/
# # #
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.